Company Filing History:
Years Active: 2024
Title: Tamás Schweighoffer: Innovator in Antibody Drug Conjugates
Introduction
Tamás Schweighoffer is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. His work focuses on innovative solutions for treating cancer, showcasing his commitment to advancing medical science.
Latest Patents
Tamás Schweighoffer holds 1 patent related to his research. The patent, titled "Anti-CD48 antibodies, antibody drug conjugates, and uses thereof," discloses antibodies and antigen binding fragments that specifically bind to human CD48. This invention includes pharmaceutical compositions that utilize these antibodies and methods for treating cancer in patients who require such interventions.
Career Highlights
Tamás Schweighoffer is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field, contributing to groundbreaking research and development in antibody therapies.
Collaborations
Throughout his career, Tamás has worked alongside esteemed colleagues such as Joseph Anthony D'Alessio and Claudia Judith Klinter. These collaborations have further enriched his research and have played a crucial role in the advancement of innovative therapeutic solutions.
Conclusion
Tamás Schweighoffer's contributions to the field of biotechnology, particularly in antibody drug conjugates, highlight his dedication to improving cancer treatment options. His innovative work continues to inspire advancements in medical research and therapy.